Immunovant Stock Probability of Future Stock Price Finishing Over 28.73
| IMVT Stock | USD 19.64 0.05 0.25% |
Immunovant |
Immunovant Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Immunovant for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Immunovant can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Immunovant generated a negative expected return over the last 90 days | |
| Immunovant has high historical volatility and very poor performance | |
| Immunovant has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (259.34 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Immunovant currently holds about 427.2 M in cash with (214.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.66. | |
| Roughly 58.0% of the company shares are held by company insiders |
Immunovant Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Immunovant Stock often depends not only on the future outlook of the current and potential Immunovant's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Immunovant's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 138.1 M | |
| Cash And Short Term Investments | 635.4 M |
Immunovant Technical Analysis
Immunovant's future price can be derived by breaking down and analyzing its technical indicators over time. Immunovant Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Immunovant. In general, you should focus on analyzing Immunovant Stock price patterns and their correlations with different microeconomic environments and drivers.
Immunovant Predictive Forecast Models
Immunovant's time-series forecasting models is one of many Immunovant's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Immunovant's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Immunovant
Checking the ongoing alerts about Immunovant for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Immunovant help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Immunovant generated a negative expected return over the last 90 days | |
| Immunovant has high historical volatility and very poor performance | |
| Immunovant has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (259.34 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Immunovant currently holds about 427.2 M in cash with (214.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.66. | |
| Roughly 58.0% of the company shares are held by company insiders |
Additional Tools for Immunovant Stock Analysis
When running Immunovant's price analysis, check to measure Immunovant's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunovant is operating at the current time. Most of Immunovant's value examination focuses on studying past and present price action to predict the probability of Immunovant's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunovant's price. Additionally, you may evaluate how the addition of Immunovant to your portfolios can decrease your overall portfolio volatility.